Supply Gap of 184 Million Pounds Looms, but Uranium Energy’s Stock Remains Stuck in a 46% Rut

The US Energy Information Administration has issued a stark forecast: American nuclear reactors face a shortfall of 184 million pounds of uranium over the next decade, equivalent to more than three years of consumption. That structural deficit should be music to the ears of any domestic producer. Yet shares of Uranium Energy Corp., which holds the largest uranium reserve in the United States, closed Friday at €9.36—down 8.82% for the week and roughly 46% below the January high. The disconnect between operational momentum and market sentiment has rarely been wider.

The company is in no rush to sell. During its fiscal third quarter ended April 2026, Uranium Energy reported no revenue at all—by design. Management chose to keep its entire inventory of 1.45 million pounds of U₃O₈ off the market, betting that spot prices will move higher. That stockpile was valued at approximately $127 million at quarter-end. For the nine-month period, total revenue reached $20.2 million, a figure that reflects the company’s deliberate strategy of remaining unhedged on its uranium sales.

That patience is underpinned by a formidable balance sheet. Uranium Energy holds $794 million in liquidity, with $488 million in pure cash and not a dollar of debt. The war chest gives the company the luxury of time to wait for better pricing, but it hasn’t insulated the stock from a brutal correction. The 50-day moving average of roughly €11.50 and the 200-day average of €11.92 both sit well above the current price, while the relative strength index at 39.8 has slipped into oversold territory.

The operational picture, however, is strengthening. Uranium Energy now operates two of its three in-situ recovery platforms in the US. Production at the Burke Hollow project—the largest new ISR uranium mine to come online in the US in over a decade—has successfully started. Meanwhile, regulatory approvals have been granted to expand capacity at the Christensen Ranch in Wyoming. Together, these two mines are expected to run at full tilt in the fourth quarter, and management anticipates higher production volumes and lower unit costs.

Costs have been a near-term headache. In the third quarter, all-in production costs came in at $54.61 per pound, driven higher by timing effects from new permits and elevated state taxes. But over the entire production life to date—roughly 276,500 pounds—the average cost is a much more competitive $39.30 per pound. The company has also completed the drilling program at the Ludeman project, a third mine that will eventually feed the central Irigaray processing plant.

Should investors sell immediately? Or is it worth buying Uranium Energy?

Strategic ambitions extend beyond mining. A subsidiary of Uranium Energy has received a docket number from the US Nuclear Regulatory Commission for a planned uranium conversion facility. Working with engineering firm Fluor Corporation, the company is progressing through site selection and engineering work before filing a formal license application. The goal: to become the only US company capable of covering the full nuclear fuel cycle from mining through conversion.

Washington is adding fuel to that ambition. In April, the Department of Energy launched the “Nuclear Dominance – 3 by 33” initiative, which aims to establish a competitive domestic nuclear fuel supply chain by 2033. That policy tailwind comes as demand from the technology sector accelerates. Meta and Microsoft have both secured new nuclear power capacity to feed their growing AI data centers, adding further pressure to an already tight uranium market.

Spot uranium prices have been hovering around $85 per pound and rose nearly 10% in June. Uranium futures trade at similar levels. The company’s unhedged stance means it can capture any further upside directly. But the market has so far chosen to focus on the stock’s technical damage rather than the fundamental story.

Wall Street analysts remain firmly bullish. Of the nine covering the stock, eight rate it a buy and one a hold. The consensus price target stands at $18.25, while one investment bank reaffirmed a target of $26.75 as recently as mid-June, based on a discounted cash flow valuation and two times net asset value. Roth MKM also reiterated its buy rating.

The fourth quarter will be pivotal. With Burke Hollow and Christensen Ranch both operating for a full three-month period, investors will get a clear read on whether the company can deliver the production ramp-up it has promised. If the numbers come through, they could finally bridge the gap between a stock that looks beaten down and a company that is building out the infrastructure for America’s nuclear resurgence.